Persiani S - Search Results

1

Strategies to assess the drug interaction potential in translational medicine.

Persiani S, Larger P. Persiani S, et al. Expert Opin Drug Metab Toxicol. 2006 Oct;2(5):675-86. doi: 10.1517/17425255.2.5.675. Expert Opin Drug Metab Toxicol. 2006. PMID: 17014388 Review.

2

In vitro study of the inhibition and induction of human cytochromes P450 by crystalline glucosamine sulfate.

Persiani S, Canciani L, Larger P, Rotini R, Trisolino G, Antonioli D, Rovati LC. Persiani S, et al. Drug Metabol Drug Interact. 2009;24(2-4):195-209. doi: 10.1515/dmdi.2009.24.2-4.195. Drug Metabol Drug Interact. 2009. PMID: 20408500

3

Glucosamine binding to proteins in plasma and synovial fluid and blood cell/plasma partitioning in mouse and man in vitro.

Persiani S, Matthews A, Larger P, Hall M, Rotini R, Trisolino G, Antonioli D, Zaccarelli L, Rovati LC. Persiani S, et al. Drug Metabol Drug Interact. 2009;24(2-4):211-27. doi: 10.1515/dmdi.2009.24.2-4.211. Drug Metabol Drug Interact. 2009. PMID: 20408501

4

Translational medicine 2006.

Persiani S. Persiani S. IDrugs. 2006 Apr;9(4):253-5. IDrugs. 2006. PMID: 16596476 No abstract available.

5

Pharmacokinetic profile of dexloxiglumide.

Persiani S, D'Amato M, Jakate A, Roy P, Wangsa J, Kapil R, Rovati LC. Persiani S, et al. Clin Pharmacokinet. 2006;45(12):1177-88. doi: 10.2165/00003088-200645120-00003. Clin Pharmacokinet. 2006. PMID: 17112294 Review.

6

Silibinin hemisuccinate binding to proteins in plasma and blood cell/plasma partitioning in mouse, rat, dog and man in vitro.

Persiani S, Sala F, Cole R, Webber G, Caselli G, Vaghi P, Rovati LC. Persiani S, et al. Drug Metabol Drug Interact. 2013;28(2):115-22. doi: 10.1515/dmdi-2013-0013. Drug Metabol Drug Interact. 2013. PMID: 23612650

7

Absorption, distribution, metabolism and excretion of the cholecystokinin-1 antagonist dexloxiglumide in the dog.

Webber C, Stokes CA, Persiani S, Makovec F, McBurney A, Kapil RP, John BA, D'Amato M, Chasseaud LF. Webber C, et al. Among authors: persiani s. Eur J Drug Metab Pharmacokinet. 2004 Jan-Mar;29(1):15-23. doi: 10.1007/BF03190569. Eur J Drug Metab Pharmacokinet. 2004. PMID: 15151166

8

Pharmacokinetics of andolast after administration of single escalating doses by inhalation in mild asthmatic patients.

Persiani S, D'Amato M, Makovec F, Arshad SH, Holgate ST, Rovati LC. Persiani S, et al. Biopharm Drug Dispos. 2001 Mar;22(2):73-81. doi: 10.1002/bdd.260. Biopharm Drug Dispos. 2001. PMID: 11745909 Clinical Trial.

9

Pharmacological characterisation of CR6086, a potent prostaglandin E₂ receptor 4 antagonist, as a new potential disease-modifying anti-rheumatic drug.

Caselli G, Bonazzi A, Lanza M, Ferrari F, Maggioni D, Ferioli C, Giambelli R, Comi E, Zerbi S, Perrella M, Letari O, Di Luccio E, Colovic M, Persiani S, Zanelli T, Mennuni L, Piepoli T, Rovati LC. Caselli G, et al. Among authors: persiani s. Arthritis Res Ther. 2018 Mar 1;20(1):39. doi: 10.1186/s13075-018-1537-8. Arthritis Res Ther. 2018. PMID: 29490676 Free PMC article.

10

Synovial and plasma glucosamine concentrations in osteoarthritic patients following oral crystalline glucosamine sulphate at therapeutic dose.

Persiani S, Rotini R, Trisolino G, Rovati LC, Locatelli M, Paganini D, Antonioli D, Roda A. Persiani S, et al. Osteoarthritis Cartilage. 2007 Jul;15(7):764-72. doi: 10.1016/j.joca.2007.01.019. Epub 2007 Mar 13. Osteoarthritis Cartilage. 2007. PMID: 17353133 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59 results

Search Page

Filters